Aspergillus sensitisation: an underappreciated treatable trait in airway disease

Jennifer Pollock; James D. Chalmers

doi:10.1183/13993003.02042-2022

Aspergillus sensitisation: an underappreciated treatable trait in airway disease

Jennifer Pollock, James D. Chalmers (Lead / Corresponding author)

Molecular and Clinical Medicine

Research output: Contribution to journal › Editorial › peer-review

Abstract

Sensitisation to Aspergillus is associated with increased exacerbations in patients with COPD.

Original language	English
Article number	2202042
Journal	European Respiratory Journal
Volume	61
Issue number	1
DOIs	https://doi.org/10.1183/13993003.02042-2022
Publication status	Published - 6 Jan 2023

Keywords

Humans
Aspergillus fumigatus/immunology
Allergens
Aspergillus
Asthma/drug therapy
Respiration Disorders
Pulmonary Disease, Chronic Obstructive

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.02042-2022

Cite this

@article{05238a777b194cd4bd695d2ec5e8a82b,

title = "Aspergillus sensitisation: an underappreciated treatable trait in airway disease",

abstract = "Sensitisation to Aspergillus is associated with increased exacerbations in patients with COPD.",

keywords = "Humans, Aspergillus fumigatus/immunology, Allergens, Aspergillus, Asthma/drug therapy, Respiration Disorders, Pulmonary Disease, Chronic Obstructive",

author = "Jennifer Pollock and Chalmers, {James D.}",

note = "Funding Information: Asthma and Lung UK Copyright: {\textcopyright}The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org",

year = "2023",

month = jan,

day = "6",

doi = "10.1183/13993003.02042-2022",

language = "English",

volume = "61",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Aspergillus sensitisation

T2 - an underappreciated treatable trait in airway disease

AU - Pollock, Jennifer

AU - Chalmers, James D.

N1 - Funding Information: Asthma and Lung UK Copyright: ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org

PY - 2023/1/6

Y1 - 2023/1/6

N2 - Sensitisation to Aspergillus is associated with increased exacerbations in patients with COPD.

AB - Sensitisation to Aspergillus is associated with increased exacerbations in patients with COPD.

KW - Humans

KW - Aspergillus fumigatus/immunology

KW - Allergens

KW - Aspergillus

KW - Asthma/drug therapy

KW - Respiration Disorders

KW - Pulmonary Disease, Chronic Obstructive

UR - http://www.scopus.com/inward/record.url?scp=85145870219&partnerID=8YFLogxK

U2 - 10.1183/13993003.02042-2022

DO - 10.1183/13993003.02042-2022

M3 - Editorial

C2 - 36609522

SN - 0903-1936

VL - 61

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 1

M1 - 2202042

ER -

Aspergillus sensitisation: an underappreciated treatable trait in airway disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this